首页> 外文期刊>Journal of clinical anesthesia >Comparison of fentanyl and sufentanil in combination with bupivacaine for patient-controlled epidural analgesia during labor.
【24h】

Comparison of fentanyl and sufentanil in combination with bupivacaine for patient-controlled epidural analgesia during labor.

机译:芬太尼和舒芬太尼联合布比卡因用于分娩期间患者自控硬膜外镇痛的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

STUDY OBJECTIVES: To compare the efficacy of fentanyl plus bupivacaine with sufentanil plus bupivacaine for treatment of pain during labor and delivery using patient-controlled epidural analgesia (PCEA). DESIGN: Prospective, double-blind, clinical investigation. SETTINGS: University-affiliated hospital. PATIENTS: 226 ASA physical status I and II laboring patients. INTERVENTIONS: Patients were randomized to receive 0.125% bupivacaine with fentanyl (2 micro g.ml(-1)) or 0.125% bupivacaine with sufentanil (0.25 micro g.ml(-1)) through PCEA. MEASUREMENTS: Maternal analgesia assessed by visual analog scale was recorded before epidural block, 1 and 3 hours after epidural block, at full cervical dilation, and at delivery. Motor blockade assessed by Bromage scale was recorded at delivery. MAIN RESULTS: Nine patients in group fentanyl, and 11 in group sufentanil were excluded from the study. Overall analgesia was good and no difference was observed between the two groups. Total boluses of 4 mL bupivacaine-opioid administered and the number of supplementary top-up injections of 5 mL 0.25% bupivacaine were similar in both groups. In group sufentanil, motor blockade and pruritus were significantly lower than in group fentanyl. Nausea was not recorded in any patients. Mode of delivery was similar in both groups, i.e., cesarean section, vacuum or forceps, or spontaneous vaginal delivery. No difference was observed in Apgar scores. CONCLUSIONS: Sufentanil is preferable to fentanyl during bupivacaine PCEA as there is less incidence of motor blockade and pruritus.
机译:研究目的:比较芬太尼加布比卡因与舒芬太尼加布比卡因在硬膜外分娩中使用患者自控硬膜外镇痛(PCEA)治疗疼痛的疗效。设计:前瞻性,双盲,临床研究。单位:大学附属医院。患者:226名ASA身体状况I和II劳动患者。干预措施:患者通过PCEA随机接受0.125%布比卡因联合芬太尼(2 micro g.ml(-1))或0.125%布比卡因联合舒芬太尼(0.25 micro g.ml(-1))。测量:在硬膜外阻滞前,硬膜外阻滞后1和3小时,完全宫颈扩张和分娩时,记录通过视觉模拟量表评估的母亲镇痛效果。在交付时记录通过Bromage量表评估的运动阻滞。主要结果:芬太尼组9例,舒芬太尼组11例被排除在研究之外。总体镇痛效果良好,两组之间无差异。两组的总剂量分别为4 mL布比卡因-阿片类药物和补充充注5 mL 0.25%布比卡因的次数。舒芬太尼组的运动阻滞和瘙痒明显低于芬太尼组。未在任何患者中记录到恶心。两组的分娩方式相似,即剖宫产,真空或镊子或自然阴道分娩。 Apgar评分未见差异。结论:布比卡因PCEA期间舒芬太尼优于芬太尼,因为其运动阻滞和瘙痒的发生率较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号